1. Home
  2. HUT vs LEGN Comparison

HUT vs LEGN Comparison

Compare HUT & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hut 8 Corp.

HUT

Hut 8 Corp.

HOLD

Current Price

$106.37

Market Cap

5.5B

Sector

Finance

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$29.30

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUT
LEGN
Founded
2011
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.9B
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
HUT
LEGN
Price
$106.37
$29.30
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
12
Target Price
$65.20
$61.33
AVG Volume (30 Days)
4.8M
2.3M
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$235,118,000.00
N/A
Revenue This Year
$161.69
$42.68
Revenue Next Year
N/A
$30.52
P/E Ratio
N/A
N/A
Revenue Growth
44.79
N/A
52 Week Low
$14.74
$16.24
52 Week High
$112.26
$45.30

Technical Indicators

Market Signals
Indicator
HUT
LEGN
Relative Strength Index (RSI) 64.84 65.66
Support Level $46.25 $25.01
Resistance Level $112.26 $29.69
Average True Range (ATR) 8.73 2.17
MACD -0.53 -0.12
Stochastic Oscillator 82.93 82.32

Price Performance

Historical Comparison
HUT
LEGN

About HUT Hut 8 Corp.

Hut 8 Corp is an energy infrastructure platform that integrates power, digital infrastructure, and compute at scale to fuel next-generation, energy-intensive use cases. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: